Research review
Does turmeric help with dementia? What the research does and doesn't show
The one placebo-controlled trial that tested oral curcumin directly in people with diagnosed Alzheimer's disease found no clinical or biomarker benefit over 24 weeks, even at doses up to 4 grams a day. Separately, a handful of small trials in people without dementia have found curcumin improved working memory specifically, not overall cognitive function.
The evidence doesn't support turmeric or curcumin as a treatment for dementia. The one placebo-controlled trial that tested oral curcumin directly in people diagnosed with Alzheimer's disease found no significant difference from placebo on cognitive scores or brain biomarkers over 24 weeks, even at doses up to 4 grams a day. Separately, a handful of small trials in people without dementia found curcumin improved working memory specifically — a narrow result, not general cognitive protection.
What the evidence doesn't support
It doesn't support curcumin as a treatment for Alzheimer's disease — the only trial that tested it directly in a diagnosed population found no clinical or biomarker benefit. It doesn't support curcumin as a general cognitive enhancer, since the small positive trials that exist found a benefit only on working memory, not on language, episodic memory, cognitive flexibility or overall cognitive function. And it doesn't support turmeric root powder for either question, since every trial reviewed here used a concentrated curcumin extract.
What the trials found
The most directly relevant trial is a 24-week, double-blind, placebo-controlled study in 36 people with diagnosed mild-to-moderate Alzheimer's disease, randomized to placebo, 2,000 mg/day or 4,000 mg/day of oral curcumin. Among the 30 who completed it (mean age 73.5), there was no significant difference between curcumin and placebo on the ADAS-Cog cognitive test, or on a set of amyloid, tau and oxidative-stress biomarkers measured in blood and spinal fluid. Curcumin was tolerated at those high doses, though 3 of 24 people on curcumin withdrew for gastrointestinal symptoms, and even at 4,000 mg/day, measured blood levels of curcumin stayed very low — consistent with curcumin's well-documented poor absorption. The trial's own authors concluded they couldn't demonstrate clinical or biochemical evidence of a benefit.
Outside of diagnosed Alzheimer's disease, a 2018 review of curcumin and cognitive decline identified 5 relevant randomized controlled trials. Only 2 of the 5 found any benefit at all, and both of those were specifically on working memory — not overall cognitive function. The review noted that none of the 5 trials tested people with elevated inflammation or measured inflammatory markers directly, despite chronic inflammation being the proposed mechanism for curcumin's effect on cognition, and that study populations, doses and cognitive tests varied widely across the small pool.
A broader meta-analysis of 8 trials (389 people, mixed populations, not specifically dementia patients) found the same narrow pattern: a significant improvement in working memory with curcumin versus placebo, but no significant difference on language, episodic or verbal memory, cognitive flexibility, or overall cognitive function. The same meta-analysis found a significantly higher rate of gastrointestinal adverse events with curcumin than placebo.
No trial reviewed here found curcumin improved overall cognitive function in a diagnosed dementia population, and no trial tested turmeric powder for cognition.
Questions people ask
Does turmeric help prevent Alzheimer's or dementia?
No trial has tested curcumin for preventing dementia. The one trial that gave curcumin to people already diagnosed with Alzheimer's disease found no clinical or biomarker benefit over 24 weeks.
Does turmeric improve memory?
The evidence for that is narrower than the question. A handful of small trials found curcumin improved working memory (holding and manipulating information short-term) specifically, but not other kinds of memory or overall cognitive function, and none of those trials were in people with diagnosed memory loss or dementia.
How much turmeric should I take for brain health?
There isn't an established dose. The Alzheimer's trial used up to 4,000 mg/day of a standardized curcumin extract and found no benefit at that dose; the smaller working-memory trials used different amounts. None of it applies to turmeric root powder.
When to talk to a doctor
Memory loss, confusion, or other signs of cognitive decline are worth evaluating with a doctor, who can assess for a treatable cause and discuss options. Turmeric and curcumin are not a treatment for dementia, Alzheimer's disease or cognitive decline, and nothing in the evidence above supports using either as a substitute for that evaluation. If you take medication, or are pregnant or nursing, talk to a doctor before adding any supplement.
Related reading: turmeric benefits: what the research does and doesn't show, turmeric and ashwagandha, and how much turmeric should you take a day?
Sources
- Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study A 24-week, placebo-controlled trial in 36 people with diagnosed mild-to-moderate Alzheimer's disease found no significant difference between curcumin (up to 4,000 mg/day) and placebo on a standard cognitive test or on amyloid and tau biomarkers; curcumin was generally well tolerated, though 3 people withdrew for gastrointestinal symptoms, and blood levels of curcumin stayed very low even at the highest dose.
- Can Curcumin Counteract Cognitive Decline? Clinical Trial Evidence and Rationale for Combining ω-3 Fatty Acids with Curcumin A 2018 review identified 5 randomized controlled trials testing curcumin's effect on cognition; only 2 of the 5 found any benefit, and both of those were specifically on working memory rather than overall cognitive function, with study quality and design varying widely across the small pool.
- The Effect of Curcumin Differs on Individual Cognitive Domains across Different Patient Populations: A Systematic Review and Meta-Analysis A 2021 meta-analysis of 8 RCTs (389 people) found curcumin significantly increased the odds of gastrointestinal adverse events versus placebo (OR 3.02) — reported as one general category, not broken into diarrhea, constipation or bloating specifically.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.